Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.

OBJECTIVE The morbidity and mortality of hospitalized GCA patients have been unexplored. The aim of this study was to analyse inpatient complications experienced by patients with GCA. METHODS We used the Nationwide Inpatient Sample database to study a large group of patients admitted for pneumonia, myocardial infarction (MI), ischaemic stroke and femoral neck fracture. Patients were divided into two groups based on whether or not they had a diagnosis of GCA upon admission. Outcomes evaluated included inpatient mortality and the occurrence of adrenal insufficiency, deep vein thrombosis, pulmonary embolism and delirium. RESULTS From 2008 to 2011, 8 203 447 patients ≥50 years of age were discharged from US hospitals after admission with pneumonia, MI, stroke and femoral neck fracture. Among these patients, 9311 (0.11%) had GCA. Admissions for pneumonia, stroke and hip fracture were more frequent in GCA patients compared with those without GCA, accounting for 41.5% vs 39.4%, 24.9% vs 19.8% and 15.4% vs 14.2% of hospitalizations, respectively (P ≤ 0.001). Admissions for MI were more common in non-GCA patients (26.6% vs 18.2%, P < 0.001). During hospitalization, 4.1% of the GCA patients died, compared with 4.8% of those without GCA [odds ratio (OR) 0.73, P < 0.001). The GCA population suffered significantly more often from deep vein thrombosis (OR 2.08, P < 0.001), pulmonary embolism (OR 1.58, P < 0.001), delirium (OR 1.60, P < 0.001) and adrenal insufficiency (OR 4.95, P < 0.001). CONCLUSION Hospitalized GCA patients have lower mortality compared with the general inpatient population but greater risk of venous thromboembolism, delirium and adrenal insufficiency.

[1]  P. Merkel,et al.  Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden , 2014, Annals of the rheumatic diseases.

[2]  E. Kimchi,et al.  Delirium in elderly people – Authors'reply , 2014, The Lancet.

[3]  C. Brymer,et al.  Prognosis of delirium in hospitalized elderly: worse than we thought , 2014, International journal of geriatric psychiatry.

[4]  J. Saczynski,et al.  Delirium in elderly people , 2014, The Lancet.

[5]  L. Trupin,et al.  A168: Systemic Lupus Erythematosus In‐Hospital Mortality Risk Across Ages: A National Estimate , 2014 .

[6]  M. Chung,et al.  The impact of age on the epidemiology of atrial fibrillation hospitalizations. , 2014, The American journal of medicine.

[7]  P. Merkel,et al.  Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis , 2014, Annals of Internal Medicine.

[8]  V. Neuhaus,et al.  Psychiatric Disorders and Major Spine Surgery: Epidemiology and Perioperative Outcomes , 2014, Spine.

[9]  G. Gondran,et al.  Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study , 2013, PloS one.

[10]  C. Whitney,et al.  U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. , 2013, The New England journal of medicine.

[11]  J. Springer,et al.  Thrombosis in vasculitis , 2013, Current opinion in rheumatology.

[12]  S. Gabriel,et al.  Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis , 2012, Annals of the rheumatic diseases.

[13]  J. Kopec,et al.  Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study , 2012, Arthritis Research & Therapy.

[14]  A. Coleman,et al.  Risk of fractures following cataract surgery in Medicare beneficiaries. , 2012, JAMA.

[15]  K. Kraemer,et al.  Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. , 2012, Arthritis and rheumatism.

[16]  Gordon H Guyatt,et al.  Executive Summary Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2012 .

[17]  J. Sundquist,et al.  Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden , 2012, The Lancet.

[18]  C. Hill,et al.  Mortality in Patients with Biopsy-proven Giant Cell Arteritis: A South Australian Population-based Study , 2011, The Journal of Rheumatology.

[19]  Sreeram V Ramagopalan,et al.  Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.

[20]  H. Erdem,et al.  Investigation of the veins in patients with Behçet’s disease with no known vascular event by Doppler ultrasonography , 2012, Rheumatology International.

[21]  K. Barraclough,et al.  BSR and BHPR guidelines for the management of giant cell arteritis. , 2010, Rheumatology.

[22]  Liang‐Kung Chen,et al.  Ischemic stroke in the elderly: an overview of evidence , 2010, Nature Reviews Neurology.

[23]  H. B. Fung,et al.  Community-acquired pneumonia in the elderly. , 2010, The American journal of geriatric pharmacotherapy.

[24]  S. Bornstein Predisposing factors for adrenal insufficiency. , 2009, The New England journal of medicine.

[25]  L. Calabrese,et al.  Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. , 2009, Arthritis and rheumatism.

[26]  Marcelo Coca-Perraillon,et al.  Incidence and mortality of hip fractures in the United States. , 2009, JAMA.

[27]  K. Digre,et al.  Giant cell arteritis and mortality. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[28]  R. Seror,et al.  High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients , 2008, Annals of the rheumatic diseases.

[29]  P. Marik,et al.  Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. , 2008, Archives of surgery.

[30]  G. Hunder,et al.  Polymyalgia rheumatica and giant-cell arteritis , 2008, The Lancet.

[31]  E. Chakravarty,et al.  Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. , 2007, Rheumatology.

[32]  G. Rubenfeld,et al.  Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. , 2007, JAMA.

[33]  M. Naylor,et al.  Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[34]  J. Wakim,et al.  Anesthetic implications for patients receiving exogenous corticosteroids. , 2006, AANA journal.

[35]  P. Merkel,et al.  Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study , 2005, Annals of Internal Medicine.

[36]  S. Gabriel,et al.  Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. , 2004, Arthritis and rheumatism.

[37]  S. Gabriel,et al.  Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. , 2003, Arthritis and rheumatism.

[38]  M. Cooper,et al.  Corticosteroid insufficiency in acutely ill patients. , 2003, The New England journal of medicine.

[39]  L. Nyström,et al.  Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. , 2002, The Journal of rheumatology.

[40]  K. Wood,et al.  Corticosteroid supplementation for adrenal insufficiency. , 2002, JAMA.

[41]  T. Wilsgaard,et al.  Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. , 2001, Rheumatology.

[42]  D. Ibañez,et al.  Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. , 1997, The Journal of rheumatology.

[43]  G. Hunder,et al.  Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. , 1996, The American journal of medicine.

[44]  R. Ratner,et al.  Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. , 1993, The American journal of medicine.

[45]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[46]  V. James,et al.  Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. , 1967, Lancet.